Table 7 Base-case EORTC QLQ-C30 MID estimates
From: Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer
Linear Regression model | Distribution-based approach (MCD) | ||||
|---|---|---|---|---|---|
Scale | Improve | Deteriorate | 0.3 | 0.5 | SEM |
PFa | 2.75 to 6.37 (3.64) | -6.58 to -3.01 (-4.28) | 5.37 4 | 7.59 | 7.59 |
RFa | 5.39 to 9.25 (6.31) | -8.12 to -6.43 (-7.11) | 13.63 | 8.2 | 11.57 |
EF | 4.39 to 5.08 (4.65) | -4.96 to -1.96 (-3.41) | 10.72 | 6.43 | 9.09 |
CF | 2.18 to 2.68 (2.44)b | -3.13 to -2.90 (-3.03) | 10.11 | 6.06 | 8.58 |
SF | 4.98 to 5.81 (5.41) | -7.04 to -4.12 (-5.56) | 12.93 | 7.77 | 10.97 |
FAa | 4.95 to 7.23 (5.76) | -8.27 to -6.47 (-6.93) | 11.48 | 6.89 | 9.76 |
NV | 1.16 to 2.71 (1.86) | -2.26 to -2.12 (-2.19) | 5.86 | 3.52 | 4.98 |
PA | 3.39 to 5.37 (4.31) | -7.36 to -5.48 (-6.54) | 12 | 7.2 | 10.18 |
DY | 0.25 to 2.11 (1.39)b | -4.48 to -3.29 (-4.08) | 10.49 | 6.29 | 8.9 |
SL | 4.43 to 7.01 (5.63) | -6.18 to -5.05 (-5.70) | 14.64 | 8.78 | 12.42 |
AP | 3.00 to 4.85 (3.84) | -4.87 to -2.32 (-3.42) | 11.71 | 7.03 | 9.94 |